IQVIA Operating Cash Flow decreased by 15.9% to $618.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $568.00M to $618.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $539.00M | $844.00M | $692.00M | $508.00M | $329.00M | $863.00M | $560.00M | $417.00M | $402.00M | $583.00M | $747.00M | $522.00M | $588.00M | $721.00M | $885.00M | $568.00M | $443.00M | $908.00M | $735.00M | $618.00M |
| QoQ Change | — | +56.6% | -18.0% | -26.6% | -35.2% | +162.3% | -35.1% | -25.5% | -3.6% | +45.0% | +28.1% | -30.1% | +12.6% | +22.6% | +22.7% | -35.8% | -22.0% | +105.0% | -19.1% | -15.9% |
| YoY Change | — | — | — | — | -39.0% | +2.3% | -19.1% | -17.9% | +22.2% | -32.4% | +33.4% | +25.2% | +46.3% | +23.7% | +18.5% | +8.8% | -24.7% | +25.9% | -16.9% | +8.8% |